My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Revive Therapeutics Ltd (OP:RVVTF)

0.0083 -0.0021 (-20.19%)
Streaming Delayed Price Updated: 12:41 PM EDT, Sep 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Revive Therapeutics Ltd

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
These OTC Securities Had the Most Trading Activity in July
Photo by Federico Beccari on Unsplash In July, O... 
Via Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Psychedelics As A Potential Form Of Treatment For Traumatic Brain Injuries
In recent years, there has been a re-emergence in the study of psychedelic drug... 
Via Benzinga
Marijuana And Mushroom Stock Category Down 4% In July; Now +24% YTD
We detail how he pot- and psychedelic-related stock sector performed in the last week, during the month of July, and YTD and the stocks that moved +/-5% last week, and why. 
Via Talk Markets
Topics Cannabis
Marijuana Vs. Mushroom Psychedelic Drug Stocks: A Current & YTD Performance Comparison
We identify the performance of the top 8 clinical-stage psychedelic companies in each of the marijuana and mushroom drug stock categories during the past 5 trading days, July to date, and YTD. 
Via Talk Markets
Topics Cannabis
Pot Stocks Down In June - Remain +29.6% YTD
There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each... 
Via Talk Markets
Topics Cannabis
The Cannabis-Centric BioPharma Stocks Index Declined In April But Remains Up YTD
13 cannabis-centric clinical-stage biopharmaceutical companies and their major operational activities in April to assist those considering investing in this marijuana sub-category, 
Via Talk Markets
Topics Cannabis
Majority Of Pure-Play Psychedelic Drug Stocks Went Up Last Week
41 psychedelic drug stocks trade on the various North American stock exchanges and in the past week 24 went up, 12 went down and 5 had no change in price. 
Via Talk Markets
Cannabis-Centric Bio-Pharma Stocks Category Declined Almost 3% This Past Week
Introducing our new Cannabis-Centric Bio-Pharma Stocks Index of the 13 clinical-stage biopharmaceutical companies involved exclusively in the development of drugs using CBD and THC. 
Via Talk Markets
Pure-Play Psychedelic Drug Stocks Index Declined 5.7% This Week
In the past week, of the 41 psychedelic drug stocks that trade on the various North American stock exchanges only nine went up, in price while 31 went down and one had no change. 
Via Talk Markets
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027
Via FinancialNewsMedia
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.